27
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      OncoTargets and Therapy (submit here)

      This international, peer-reviewed Open Access journal by Dove Medical Press focuses on the pathological basis of cancers, potential targets for therapy and treatment protocols to improve the management of cancer patients. Publishing high-quality, original research on molecular aspects of cancer, including the molecular diagnosis, since 2008. Sign up for email alerts here. 50,877 Monthly downloads/views I 4.345 Impact Factor I 7.0 CiteScore I 0.81 Source Normalized Impact per Paper (SNIP) I 0.811 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Role Of Robot-Assisted Partial Nephrectomy For Renal Cell Carcinomas In The Purpose Of Nephron Sparing

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          Surgery remains the standard treatment for localized renal cell carcinomas, and partial nephrectomy is considered before radical nephrectomy with the aim of preserving renal function. This study aimed to compare robot-assisted and open partial nephrectomy for the purpose of nephron sparing.

          Materials and methods

          We retrospectively enrolled consecutive patients who received partial nephrectomy at a single tertiary medical center from January 2008 to January 2015. Medical records and radiographic images were reviewed. We analyzed the patients’ general characteristics, underlying disease, complications, length of hospital stay, renal tumor complexity, surgery type, renal function, and specimen and tumor size. A comparison between open and robot-assisted nephrectomy groups was performed.

          Results

          A total of 136 patients were enrolled, with a male to female ratio of 2:3 and a mean age of 57.8 years. Of these, 71 and 65 patients received open and robot-assisted surgery, respectively. Compared with the open group, patients who underwent robot-assisted surgery were significantly younger (56.0 versus 60.1 years old), had a longer operative time (303 versus 224 min), and a lower kidney ischemic time (33.4 versus 46.9 min). Given similar tumor sizes, the tumor-to-excision ratio was significantly higher in the robot-assisted group (51.7% versus 39.8%), and the excisional volume loss (EVL) was smaller (12.7 versus 19.6 mL). Preoperative glomerular filtration rate and EVL were significant predictors of long-term renal function preservation in the multivariate analysis.

          Conclusion

          When performing partial nephrectomy, a robot-assisted procedure could increase the accuracy of excision without increasing the risk of positive surgical margin. Lower EVL could assist in better long-term postoperative renal function preservation.

          Most cited references26

          • Record: found
          • Abstract: not found
          • Article: not found

          Guideline for management of the clinical T1 renal mass.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study.

            Chronic kidney disease is a graded and independent risk factor for substantial comorbidity and death. We aimed to examine new onset of chronic kidney disease in patients with small, renal cortical tumours undergoing radical or partial nephrectomy. We did a retrospective cohort study of 662 patients with a normal concentration of serum creatinine and two healthy kidneys undergoing elective partial or radical nephrectomy for a solitary, renal cortical tumour (
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The changing natural history of renal cell carcinoma.

              Our understanding of the natural history of renal cell carcinoma, the role of nephrectomy, the benefits of immunotherapy and the possibilities of new technologies are evolving and being integrated with advances in classification and staging. We reviewed the relevant literature to clarify these pertinent questions and provide a current review of the changes in the epidemiology, treatment and prognosis of patients with renal cell carcinoma. We comprehensively reviewed the peer reviewed literature on the current management of and results of treatment for renal cell carcinoma. The incidence of and mortality from renal cell carcinoma have continuously increased during the last 50 years. Despite this increase in the number of new patients and consequently the number of deaths yearly the percent of those surviving for 5 years has notably improved. Factors related to improved survival include advances in renal imaging, earlier diagnosis, improved staging, better understanding of prognostic indicators, refinement in surgical technique and the introduction of immunotherapy approaches for advanced disease. Currently patients with localized and metastatic renal cell carcinoma have had improvements in outlook and the therapeutic options available have expanded.
                Bookmark

                Author and article information

                Journal
                Onco Targets Ther
                Onco Targets Ther
                OTT
                ott
                OncoTargets and therapy
                Dove
                1178-6930
                04 October 2019
                2019
                : 12
                : 8189-8196
                Affiliations
                [1 ]Division of Urology, Department of Surgery, LinKou Chang Gung Memorial Hospital , Taoyuan, Taiwan
                [2 ]College of Medicine, Chang Gung University , Taoyuan, Taiwan
                [3 ]Division of Urology, Department of Surgery, KeeLung Chang Gung Memorial Hospital , KeeLung, Taiwan
                Author notes
                Correspondence: Cheng-Keng Chuang; Ying-Hsu Chang Division of Urology, Department of Surgery, Chang Gung Memorial Hospital , 5 Fu-Shing Street, Kweishan, Taoyuan333, TaiwanTel +886-3-3281200 Ext 2103Fax +886-3-3285818 Email chuang89@cgmh.org.tw; anatomy@cgmh.org.tw
                Author information
                http://orcid.org/0000-0002-4832-0113
                http://orcid.org/0000-0002-6579-4775
                http://orcid.org/0000-0001-8245-4302
                http://orcid.org/0000-0001-6154-1220
                Article
                214060
                10.2147/OTT.S214060
                6781943
                66b1da91-ec26-46b7-9eed-27c8eee4fd81
                © 2019 Shao et al.

                This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

                History
                : 01 May 2019
                : 10 September 2019
                Page count
                Figures: 3, Tables: 4, References: 27, Pages: 8
                Categories
                Original Research

                Oncology & Radiotherapy
                renal cell carcinoma,robotic-assisted system,partial nephrectomy,excisional volume loss,nephron sparing,renal function preservation

                Comments

                Comment on this article